The long-acting dopamine receptor agonist cabergoline in early Parkinson's disease: final results of a 5-year, double-blind, levodopa-controlled study.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Works matching IS 11727047 AND DT 2004 AND VI 18 AND IP 11
Results: 8
1
2
Neuropsychiatric Symptoms of Fragile X Syndrome: Pathophysiology and Pharmacotherapy.
- Published in:
- CNS Drugs, 2004, v. 18, n. 11, p. 687, doi. 10.2165/00023210-200418110-00001
- By:
- Publication type:
- Article
3
Future antidepressants: what is in the pipeline and what is missing?
- Published in:
- 2004
- By:
- Publication type:
- journal article
4
The Long-Acting Dopamine Receptor Agonist Cabergoline in Early Parkinson’s Disease: Final Results of a 5-Year, Double-Blind, Levodopa-Controlled Study.
- Published in:
- CNS Drugs, 2004, v. 18, n. 11, p. 733, doi. 10.2165/00023210-200418110-00003
- By:
- Publication type:
- Article
5
Ropinirole: for the treatment of restless legs syndrome.
- Published in:
- 2004
- By:
- Publication type:
- journal article
6
Ropinirole: A Viewpoint by Michael E. Ernst.
- Published in:
- CNS Drugs, 2004, v. 18, n. 11, p. 755, doi. 10.2165/00023210-200418110-00005
- By:
- Publication type:
- Article
7
Ropinirole : a viewpoint by björn w. Walther.
- Published in:
- 2004
- By:
- Publication type:
- journal article
8
Ropinirole: A Viewpoint by Thomas C. Wetter.
- Published in:
- CNS Drugs, 2004, v. 18, n. 11, p. 756, doi. 10.2165/00023210-200418110-00007
- By:
- Publication type:
- Article